JAZZ
Jazz Pharmaceuticals plc$236.26+6.63 (+2.89%)Prev Close$229.63·MCap$14.56B·P/E2147.86·Vol679.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
24
$32.00M
◆
Net Activity
Net Seller
$32.00M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Jazz Pharmaceuticals plc (JAZZ) has been exclusively selling, with 0 insider purchases totaling $0.00 and 24 insider sales totaling $32.00M. The most recent insider transaction was by COZADD BRUCE C (Director), who sold $2.99M worth of shares on Jan 16, 2026. Jazz Pharmaceuticals plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $14.56B.
JAZZ Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | COZADD BRUCE C | Director | Sell | 17,453 | $171.16 | $2.99M | 0 |
| Jan 16, 2026 | GALA RENEE D | President & CEO | Sell | 5,371 | $171.16 | $919.3K | 0 |
| Jan 16, 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 4,140 | $171.16 | $708.6K | 0 |
| Jan 16, 2026 | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,275 | $171.16 | $560.5K | 0 |
| Jan 16, 2026 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,599 | $171.16 | $273.7K | 0 |
| Dec 9, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 2,238 | $169.51 | $379.4K | 0 |
| Dec 5, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 4,660 | $171.20 | $797.8K | 0 |
| Dec 5, 2025 | GALA RENEE D | President & CEO | Sell | 80 | $166.91 | $13.4K | 0 |
| Dec 2, 2025 | O'Keefe Kenneth W | Director | Sell | 603 | $173.07 | $104.4K | 0 |
| Nov 26, 2025 | COZADD BRUCE C | Director | Sell | 77,500 | $177.81 | $13.78M | 0 |
| Nov 20, 2025 | McSharry Heather Ann | Director | Sell | 3,415 | $177.78 | $607.1K | 0 |
| Nov 19, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 1,331 | $180.40 | $240.1K | 0 |
| Nov 18, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 5,319 | $182.06 | $968.4K | 0 |
| Nov 18, 2025 | COZADD BRUCE C | Director | Sell | 18,000 | $181.09 | $3.26M | 0 |
| Nov 18, 2025 | Winningham Rick E | Director | Sell | 5,500 | $180.86 | $994.7K | 0 |
| Nov 17, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 7,159 | $168.26 | $1.20M | 0 |
| Oct 1, 2025 | COZADD BRUCE C | Director | Sell | 5,500 | $137.01 | $753.6K | 0 |
| Sep 14, 2025 | COZADD BRUCE C | Director | Sell | 15,647 | $126.16 | $1.97M | 0 |
| Sep 2, 2025 | COZADD BRUCE C | Director | Sell | 6,000 | $128.62 | $771.7K | 0 |
| Aug 7, 2025 | Kennedy Patrick | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025 | O'Keefe Kenneth W | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 5, 2025 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 577 | $116.10 | $67.0K | 0 |
| Aug 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $113.21 | $113.2K | 0 |
| Jul 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $107.63 | $107.6K | 0 |
| Jun 2, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $108.95 | $109.0K | 0 |
| May 9, 2025 | Mulligan Seamus | Director | Buy | 101,621 | $98.34 | $9.99M | 0 |
| May 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $117.57 | $176.3K | 0 |
| Apr 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $123.75 | $185.6K | 0 |
| Mar 10, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 2,403 | $138.41 | $332.6K | 0 |
| Mar 7, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 2,473 | $138.04 | $341.4K | 0 |
| Mar 7, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 698 | $138.23 | $96.5K | 0 |
| Mar 5, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 22,251 | $138.95 | $3.09M | 0 |
| Mar 5, 2025 | GALA RENEE D | President & COO | Sell | 5,704 | $138.95 | $792.6K | 0 |
| Mar 5, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 12,319 | $138.75 | $1.71M | 0 |
| Mar 5, 2025 | Johnson Philip L | EVP & Chief Financial Officer | Sell | 1,149 | $138.95 | $159.7K | 0 |
| Mar 5, 2025 | Patil Neena M | EVP & Chief Legal Officer | Sell | 4,088 | $138.95 | $568.0K | 0 |
| Mar 5, 2025 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,905 | $138.95 | $264.7K | 0 |
| Feb 27, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 6,454 | $144.01 | $929.5K | 0 |
| Feb 27, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 6,500 | $144.25 | $937.6K | 0 |
| Feb 27, 2025 | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,800 | $144.87 | $550.5K | 0 |
JAZZ Insider Buying Activity
The following table shows recent insider purchases of Jazz Pharmaceuticals plc (JAZZ) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 9, 2025 | Mulligan Seamus | Director | Buy | 101,621 | $98.34 | $9.99M | 0 |
JAZZ Insider Selling Activity
The following table shows recent insider sales of Jazz Pharmaceuticals plc (JAZZ) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | COZADD BRUCE C | Director | Sell | 17,453 | $171.16 | $2.99M | 0 |
| Jan 16, 2026 | GALA RENEE D | President & CEO | Sell | 5,371 | $171.16 | $919.3K | 0 |
| Jan 16, 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 4,140 | $171.16 | $708.6K | 0 |
| Jan 16, 2026 | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,275 | $171.16 | $560.5K | 0 |
| Jan 16, 2026 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,599 | $171.16 | $273.7K | 0 |
| Dec 9, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 2,238 | $169.51 | $379.4K | 0 |
| Dec 5, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 4,660 | $171.20 | $797.8K | 0 |
| Dec 5, 2025 | GALA RENEE D | President & CEO | Sell | 80 | $166.91 | $13.4K | 0 |
| Dec 2, 2025 | O'Keefe Kenneth W | Director | Sell | 603 | $173.07 | $104.4K | 0 |
| Nov 26, 2025 | COZADD BRUCE C | Director | Sell | 77,500 | $177.81 | $13.78M | 0 |
| Nov 20, 2025 | McSharry Heather Ann | Director | Sell | 3,415 | $177.78 | $607.1K | 0 |
| Nov 19, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 1,331 | $180.40 | $240.1K | 0 |
| Nov 18, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 5,319 | $182.06 | $968.4K | 0 |
| Nov 18, 2025 | COZADD BRUCE C | Director | Sell | 18,000 | $181.09 | $3.26M | 0 |
| Nov 18, 2025 | Winningham Rick E | Director | Sell | 5,500 | $180.86 | $994.7K | 0 |
| Nov 17, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 7,159 | $168.26 | $1.20M | 0 |
| Oct 1, 2025 | COZADD BRUCE C | Director | Sell | 5,500 | $137.01 | $753.6K | 0 |
| Sep 14, 2025 | COZADD BRUCE C | Director | Sell | 15,647 | $126.16 | $1.97M | 0 |
| Sep 2, 2025 | COZADD BRUCE C | Director | Sell | 6,000 | $128.62 | $771.7K | 0 |
| Aug 7, 2025 | Kennedy Patrick | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025 | O'Keefe Kenneth W | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 5, 2025 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 577 | $116.10 | $67.0K | 0 |
| Aug 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $113.21 | $113.2K | 0 |
| Jul 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $107.63 | $107.6K | 0 |
| Jun 2, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $108.95 | $109.0K | 0 |
| May 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $117.57 | $176.3K | 0 |
| Apr 1, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $123.75 | $185.6K | 0 |
| Mar 10, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 2,403 | $138.41 | $332.6K | 0 |
| Mar 7, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 2,473 | $138.04 | $341.4K | 0 |
| Mar 7, 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 698 | $138.23 | $96.5K | 0 |
| Mar 5, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 22,251 | $138.95 | $3.09M | 0 |
| Mar 5, 2025 | GALA RENEE D | President & COO | Sell | 5,704 | $138.95 | $792.6K | 0 |
| Mar 5, 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 12,319 | $138.75 | $1.71M | 0 |
| Mar 5, 2025 | Johnson Philip L | EVP & Chief Financial Officer | Sell | 1,149 | $138.95 | $159.7K | 0 |
| Mar 5, 2025 | Patil Neena M | EVP & Chief Legal Officer | Sell | 4,088 | $138.95 | $568.0K | 0 |
| Mar 5, 2025 | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,905 | $138.95 | $264.7K | 0 |
| Feb 27, 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sell | 6,454 | $144.01 | $929.5K | 0 |
| Feb 27, 2025 | COZADD BRUCE C | Chairman & CEO | Sell | 6,500 | $144.25 | $937.6K | 0 |
| Feb 27, 2025 | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,800 | $144.87 | $550.5K | 0 |
JAZZ Insiders
Similar Stocks to JAZZ
VRTX
Vertex Pharmaceuticals Incorporated
$445.17+2.17%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$613.69+2.01%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$291.70+0.14%
$40.46B
RVMD
Revolution Medicines, Inc.
$150.04+4.02%
$31.73B
UTHR
United Therapeutics Corporation
$548.23+0.76%
$23.12B
INSM
Insmed Incorporated
$97.58+6.16%
$20.41B
INCY
Incyte Corporation
$108.43+2.82%
$20.11B
MRNA
Moderna, Inc.
$49.89+8.40%
$18.89B